DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. Our mission is to improve the lives of those debilitated by degenerative diseases of the spine through innovative regenerative therapies.
Shared 2 months ago
475 views
Shared 2 years ago
425 views
Shared 2 years ago
206 views
Shared 2 years ago
844 views
Shared 2 years ago
121 views
Shared 2 years ago
407 views
Shared 2 years ago
92 views
Shared 6 years ago
271 views